KWAR23 is an anti-human SIRPalpha antibody. KWAR23 binds human SIRPalpha with high affinity and disrupts its binding to CD47. KWAR23 shows antitumor activity in combination with tumor-opsonizing antibodies and can be used in cancer immunotherapy research[1].
Molecular Weight:
(143.4 kDa)
Purity:
99.80
CAS Number:
[2243227-60-1]
Target:
CD47
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted